Ottawa Heart Institute producing alternative to technetium-99 isotopes

May 2010
CMAJ: Canadian Medical Association Journal;5/18/2010, Vol. 182 Issue 8, pE325
Academic Journal
The article offers information on Ottawa Heart Institute in Ontario, which has produced the alternative rubidium-82 for technetium-99 isotope. Technetium-99 is used for diagnosing and treating patients with cancer and heart diseases. Rubidium-82 will enable to obtain accurate images and is safer for patients. The team of doctors, chemists and researchers at the University of Ottawa Heart Institute used cyclotron, which produced fluorine-18 that helped in producing the alternative.


Related Articles

  • Ottawa Heart reports filing for medical isotope patent.  // Medical Device Daily;8/26/2011, Vol. 15 Issue 163, p5 

    The article reports on the patent filed by the University of Ottawa Heart Institute for a technology that can replace the Chalk River nuclear reactor in creating medical isotopes for heart tests.

  • Researchers find process that clears cholesterol and could reverse major cause.  // Biomedical Market Newsletter;9/12/2011, Vol. 21, p88 

    The article reports on the discovery of researchers at the University of Ottawa Heart Institute regarding the use of the ancient pathway called autophagy in mobilizing and exporting cholesterol from cells which could reverse the major cause of heart attack.

  • French at heart. Sullivan, Patrick // CMAJ: Canadian Medical Association Journal;9/19/2000, Vol. 163 Issue 6, p750 

    Focuses on the University of Ottawa Heart Institute's development of software, French@Heart, which will attempt to teach doctors medical terms in French. Need for the program in light of possible bilingual hospitals in Ontario; Discussion of aspects of the software, such as a lexicon of medical...

  • Stand by your man. Wharry, Steven // CMAJ: Canadian Medical Association Journal;2/22/2000, Vol. 162 Issue 4, p548 

    Reports that the Board of Directors at the University of Ottawa Heart institute voted to reject the resignation of its head, cardiac surgeon Wilbert Keon. Reasons for the resignation, including Keon's being caught visiting prostitutes; Reasons that the board and others rejected the resignation;...

  • Ottawa CAD study using Affymetrix SNP Array 6.0.  // Cardiovascular Devices & Drugs;Jan2008, Vol. 14 Issue 1, p16 

    The article reports that the University of Ottawa Heart Institute (UOHI) in Ontario is using the Affymetrix Genome-Wide Human single nucleotide polymorphisms (SNP) Array 6.0 for its whole-genome association study on coronary artery disease (CAD). Affymetrix noted that UOHI researchers will use...

  • Affymetrix SNP Array used in Ottawa institute's study.  // Medical Device Daily;12/17/2007, Vol. 11 Issue 228, p1 

    The article reports that the University of Ottawa Heart Institute is using the Affymetrix Genome-Wide Human SNP Array 6.0 of Affymetrix. The single nucleotide polymorphism is used for whole-genome association study on coroary artery disease (CAD). The researchers will use the array to screen the...

  • Renowned cardiac surgeon resigns post. Wharry, Steven // CMAJ: Canadian Medical Association Journal;1/25/2000, Vol. 162 Issue 2, p243 

    Discusses the resignation of Wilbert Keon, the surgeon who performed Canada's first artificial heart transplant, as head of the University of Ottawa Heart Institute following an incident involving an undercover police officer posing as a prostitute. Keon's denial that he was soliciting the...

  • The all-clear signal for rare heart arrhythmias. Strauss, Stephen // CMAJ: Canadian Medical Association Journal;3/6/2012, Vol. 184 Issue 4, pE213 

    The article reports on the case of coach Grace Verbeek, in which in 2007, her memory runs dry after she arrived at a track facility in Ottawa, Ontario. It states that the day following the incident, Verbeek underwent a battery of tests at the University of Ottawa Heart Institute and showed...

  • Limitations of free-form-text diagnostic requisitions as a tool for evaluating adherence to appropriate use criteria for transthoracic echocardiography. Banihashemi, Behnam; Maftoon, Kasra; Chow, Benjamin J. W.; Bernick, Jordan; Wells, George A.; Burwash, Ian G. // Cardiovascular Ultrasound;2015, Vol. 13 Issue 1, p59 

    Background Monitoring the adherence to Appropriateness Use Criteria (AUC) has been identified as an important component for the accreditation of echocardiography laboratories. Referral requisitions are a logical tool to rapidly determine the appropriateness of transthoracic echocardiography...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics